pSivida News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

30.03.18	FOMX To Report Data In Q3, INNT Continues To Sizzle, All Eyes On GALT (RTTNews)
20.03.18	ARNA Soars After-hours, Remoxy Now 2 Steps Away From Approval, APLS On Watch (RTTNews)
09.01.18	Parkinson's Drug Hits Shelves, Major Event Awaits ABIO In Mar, FDA Nod For NVRO (RTTNews)
12.09.17	Keep Close Watch On ALDX Today, ABBV Just Hit Another High, Fennec Uplisted (RTTNews)
30.08.17	Technical Snapshots for These Generic Drugs Stocks -- Allergan, Catalent, Tetraphase Pharma, and pSivida (PR Newswire)
25.07.17	Technical Reports on Generic Drugs Equities -- pSivida, Tetraphase Pharma, Catalyst Pharma, and Galectin Therapeutics (PR Newswire)
13.06.17	PSivida: Durasert Second Phase 3 Trial Meets Primary Efficacy Goal (RTTNews)
05.10.16	CATB Data Pushed Back To Q1, SMMT At Peak, TRIB Pounded, OTIC Hits Right Notes (RTTNews)
15.07.16	PSivida To Locate Research And Product Development Activities In U.S. Facility (RTTNews)
06.11.15	EYEG Catches Investors' Eyes, FDA Approves GILD's HIV Pill, KBIO Lays Off Staff (RTTNews)
14.07.15	AZN Gets FDA Nod, It's 22 More For ANIP, OHRP Catches Eyes, ANAC Soars (RTTNews)
20.05.15	ACHN Cuts A Deal For HCV Assets, LuViva Snubbed Again, Medidur Proves Safe (RTTNews)
19.05.15	PSivida Reports Positive Safety Data From Medidur Phase III Trial - Quick Facts (RTTNews)
11.05.15	NVRO Gets FDA Nod, ZFGN's Obesity Drug Proves Its Worth, HRTX Awaits MAGIC (RTTNews)
18.02.15	Eagle Soars, VBLT Crushed Over Drug Failure, Study Fails To Soothe CLTX (RTTNews)
07.11.14	Psivida Q1 Profit Tops Estimates - Quick Facts (RTTNews)
29.09.14	AMBI Snapped Up, ALIM's Iluvien Gets FDA Nod, GLYC Faces Glitch In Study (RTTNews)
04.09.14	Sweet News For ABT, Adherex To Change Name, FLXN's Work In Progress, INFI Rises (RTTNews)
30.06.14	PSivida Says Iluvien Gets Marketing Authorizations In 10 More EU Countries (RTTNews)
24.06.14	ASPX Awaits Results, BZYR Creating Buzz, CGIX Opens Wallet, GNCA Hits A High (RTTNews)
28.03.14	EXAS Gets FDA Panel's Thumbs Up, NRX Ropes In Partners, PRPH Breathes Easy (RTTNews)
13.03.14	RA Capital Invests $7.0 Mln In PSivida (RTTNews)
19.12.13	Pre-market Movers For Dec 19 (FB, ACN, ALIM, PSDV, GRPN, VRTX) (RTTNews)
19.12.13	ALIM, PSDV Rally After Iluvien News, GILD Lays Out Plan, REGN Gets FDA Date (RTTNews)
18.10.13	PSivida, Alimera Shares Tank As FDA Rejects Iluvien NDA - Update (RTTNews)
18.10.13	Ariad Halts Iclusig Trial; Shares Plunge Over 38% (RTTNews)
18.10.13	Pre-market Movers For Oct 18 (GE, GOOG, FB, ANAC, SLB, ARIA, PSDV, ALIM, HON) (RTTNews)
18.10.13	Alimera Sciences Gets Complete Response Letter For Iluvien - Quick Facts (RTTNews)
04.10.13	Events, Appointments, Approvals, Recommendations, and Agreements - Research Report on Elan, Alkermes, Hospira, pSivida, and Kindred (PR Newswire)
02.10.13	Did You Buy These Triple Digit Gainers? (RTTNews)
01.10.13	ACRX Files Zalviso NDA, BGMD Gets A Booster, UK's NICE Turns Nice To PSDV (RTTNews)
19.07.13	PSivida Prices Public Offering Of 3.49 Mln Shares At $3.10/shr (RTTNews)
11.07.13	PSivida Reports Interim Data From Uveitis Study - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

CieFinRichemont	163.55	17.62 %	K V
Part Grp Hldg	1’318.00	1.11 %	K V
Alcon	76.40	0.74 %	K V
Swiss Re	134.90	0.67 %	K V
Sonova Hldg	305.40	0.33 %	K V
Holcim	85.06	-0.30 %	K V
Lonza Grp	542.00	-0.40 %	K V
Roche Hldg G	264.60	-0.49 %	K V
ABB	49.27	-0.61 %	K V
Geberit	488.70	-4.18 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu pSivida Corp

Aktien Top/Flop

Meistgelesene Nachrichten